Randomised Controlled Trial (RCT) of cannabinoid replacement therapy (Nabiximols) for the management of treatment-resistant cannabis dependent patients: a study protocol

BACKGROUND: The cannabis extract nabiximols (Sativex®) effectively supresses withdrawal symptoms and cravings in treatment resistant cannabis dependent individuals, who have high relapse rates following conventional withdrawal treatments. This study examines the efficacy, safety and cost-effectivene...

Descripción completa

Detalles Bibliográficos
Autores principales: Bhardwaj, Anjali K., Allsop, David J., Copeland, Jan, McGregor, Iain S., Dunlop, Adrian, Shanahan, Marian, Bruno, Raimondo, Phung, Nghi, Montebello, Mark, Sadler, Craig, Gugusheff, Jessica, Jackson, Melissa, Luksza, Jennifer, Lintzeris, Nicholas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5960200/
https://www.ncbi.nlm.nih.gov/pubmed/29776349
http://dx.doi.org/10.1186/s12888-018-1682-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5960200/
https://www.ncbi.nlm.nih.gov/pubmed/29776349
http://dx.doi.org/10.1186/s12888-018-1682-2

Ejemplares similares